Acinic cell carcinoma overview: Difference between revisions
No edit summary |
No edit summary |
||
| Line 35: | Line 35: | ||
Acinic cell carcinoma can appear at any age however, it is common in children. | Acinic cell carcinoma can appear at any age however, it is common in children. | ||
* Acinic cell carcinoma appears in all age groups, but presents at a younger median age (approx. 52 years) than most other salivary gland cancers. | |||
* Occurrences in children are quite common. | |||
<br /> | |||
==Risk factors== | ==Risk factors== | ||
Revision as of 00:54, 2 August 2019
|
Acinic cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case studies |
|
Acinic cell carcinoma overview On the Web |
|
American Roentgen Ray Society Images of Acinic cell carcinoma overview |
|
Risk calculators and risk factors for Acinic cell carcinoma overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Acinic cell carcinoma is one of the salivary gland tumors. The symptoms of acinic cell carcinoma include enlarged salivary gland, nausea, vomiting and digestion problems. Treatments include surgery, chemotherapy, and radiation therapy. Godwin et al. first referred Acinic Cell Carcinoma almost 50 years prior. [1]
Historical Perspective
- The “acinar” term is derived from Latin term “acinus”, which means a cluster of and looks like grapes branch.
- The histological appearance is quite similar to secretory parenchymatous cells.
- Before discovering this disease, clinically Acinic Cell Carcinoma was unrecognized.
- At the time after recognizing the disease, it thought to be the nature of the tumor is benign.
- Afterward, it has been detected that the recurrence tendency of the tumor showed the possibility of the malignant nature of the tumor.
- Later WHO (World Health Organization) re-classified as a “malignant carcinoma” with low-grade behavior (2, 3).
Pathophysiology
Features of acinic cell carcinoma on fine needle aspiration include stippled chromatin and granular cytoplasm.
Microscopic Pathology
- Cytologic features of acinic cell carcinoma on fine needle aspiration:
- Chromatin stippled.
- Granular cytoplasm.
- Sheets of cells/acinar formation.
Differential diagnosis
Acinic cell carcinoma should be differentiated from parotitis, parotid gland benign tumor and mucoepidermoid carcinoma.
Epidemiology and demographics
Acinic cell carcinoma can appear at any age however, it is common in children.
- Acinic cell carcinoma appears in all age groups, but presents at a younger median age (approx. 52 years) than most other salivary gland cancers.
- Occurrences in children are quite common.
Risk factors
Radiation exposure and positive family history are known risk factors for acinic cell carcinoma.
Screening
Screening is not recommended for acinic cell carcinoma.
Natural history, prognosis and complications
Acinic cell carcinoma is a slow growing tumor and it may affect the facial nerve or other adjacent tissues depending on its location. Prognosis is most favorable when the parotid gland is involved.
History and symptoms
Acinic cell carcinoma commonly presents with a mass in the neck, difficulty in swallowing and persistent pain.
Physical Examination
Physical examination of neck may reveal a firm swelling and tenderness.
Staging
Staging of acinic cell carcinoma depends on tumor size and location.
Treatment
Patients with acinic cell carcinoma have many treatment options. The selection depends on the stage of the tumor. The options are surgery, radiation therapy, chemotherapy, or a combination of these methods.
- Surgery: Surgery is usually the main form of treatment for resectable salivary gland cancers.
- Radiation therapy: High-energy x-rays and other types of radiations are used to kill cancer cells from keep growing.
- Chemotherapy: The treatment is to use drugs to stop the growth of cancer cells either by killing the cells or by stopping them from dividing.
References
- ↑ Al-Zaher N, Obeid A, Al-Salam S, Al-Kayyali BS (2009). "Acinic cell carcinoma of the salivary glands: a literature review". Hematol Oncol Stem Cell Ther. 2 (1): 259–64. PMID 20063555.